PDB Short entry for 7EHN HEADER OXIDOREDUCTASE 30-MAR-21 7EHN TITLE HUMAN MTHFD2 IN COMPLEX WITH COMPOUND 21 AND 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL METHYLENETETRAHYDROFOLATE COMPND 3 DEHYDROGENASE/CYCLOHYDROLASE, MITOCHONDRIAL; COMPND 4 CHAIN: A, B; COMPND 5 EC: 1.5.1.15,3.5.4.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MTHFD2, NMDMC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET14B KEYWDS MTHFD2, METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2, 1C METABOLISM, KEYWDS 2 MITOCONDRIA, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR L.C.LEE,Y.H.PENG,S.Y.WU REVDAT 2 16-FEB-22 7EHN 1 JRNL REVDAT 1 11-AUG-21 7EHN 0 JRNL AUTH L.C.LEE,Y.H.PENG,H.H.CHANG,T.HSU,C.T.LU,C.H.HUANG,C.C.HSUEH, JRNL AUTH 2 F.C.KUNG,C.C.KUO,W.T.JIAANG,S.Y.WU JRNL TITL XANTHINE DERIVATIVES REVEAL AN ALLOSTERIC BINDING SITE IN JRNL TITL 2 METHYLENETETRAHYDROFOLATE DEHYDROGENASE 2 (MTHFD2). JRNL REF J.MED.CHEM. V. 64 11288 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34337952 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00663 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 38095 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.220 REMARK 3 FREE R VALUE TEST SET COUNT : 1987 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.3900 - 5.4100 0.91 2444 155 0.1743 0.1818 REMARK 3 2 5.4100 - 4.3000 0.95 2551 136 0.1720 0.2037 REMARK 3 3 4.3000 - 3.7600 0.97 2587 114 0.1775 0.2069 REMARK 3 4 3.7600 - 3.4200 0.97 2578 124 0.1956 0.2393 REMARK 3 5 3.4200 - 3.1700 0.98 2604 156 0.2123 0.2635 REMARK 3 6 3.1700 - 2.9900 0.99 2577 150 0.2145 0.2742 REMARK 3 7 2.9900 - 2.8400 0.99 2607 151 0.2339 0.3092 REMARK 3 8 2.8400 - 2.7100 0.99 2600 171 0.2322 0.2966 REMARK 3 9 2.7100 - 2.6100 0.99 2615 126 0.2397 0.3274 REMARK 3 10 2.6100 - 2.5200 0.99 2582 151 0.2447 0.2622 REMARK 3 11 2.5200 - 2.4400 0.99 2649 128 0.2479 0.2969 REMARK 3 12 2.4400 - 2.3700 0.99 2586 158 0.2493 0.3125 REMARK 3 13 2.3700 - 2.3100 0.99 2591 139 0.2550 0.3111 REMARK 3 14 2.3100 - 2.2500 0.95 2537 128 0.2750 0.3526 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7EHN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-APR-21. REMARK 100 THE DEPOSITION ID IS D_1300021514. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : TPS 05A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : LN2-COOLED, FIXED-EXIT DOUBLE REMARK 200 CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : A PAIR OF K-B FOCUSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 2.3.10 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38105 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.52200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.7.02 REMARK 200 STARTING MODEL: 7EHM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ISOPROPANOL, BIS-TRIS PH 7.1, PEG 200, REMARK 280 PEG 3350, GLYCEROL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.78000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.89000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.83500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 18.94500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 94.72500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 217 REMARK 465 ALA A 218 REMARK 465 HIS A 219 REMARK 465 GLU A 220 REMARK 465 ARG A 221 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ASP A 281 REMARK 465 PRO A 282 REMARK 465 VAL A 283 REMARK 465 THR A 284 REMARK 465 ALA A 285 REMARK 465 LYS A 286 REMARK 465 VAL A 331 REMARK 465 LEU A 332 REMARK 465 ARG A 333 REMARK 465 LEU A 334 REMARK 465 GLU A 335 REMARK 465 GLU A 336 REMARK 465 ARG A 337 REMARK 465 GLU A 338 REMARK 465 VAL A 339 REMARK 465 LEU A 340 REMARK 465 LYS A 341 REMARK 465 SER A 342 REMARK 465 LYS A 343 REMARK 465 GLU A 344 REMARK 465 LEU A 345 REMARK 465 GLY A 346 REMARK 465 VAL A 347 REMARK 465 ALA A 348 REMARK 465 THR A 349 REMARK 465 ASN A 350 REMARK 465 ALA B 218 REMARK 465 HIS B 219 REMARK 465 GLU B 220 REMARK 465 ARG B 221 REMARK 465 HIS B 280 REMARK 465 ASP B 281 REMARK 465 PRO B 282 REMARK 465 VAL B 283 REMARK 465 THR B 284 REMARK 465 ALA B 285 REMARK 465 LYS B 286 REMARK 465 VAL B 331 REMARK 465 LEU B 332 REMARK 465 ARG B 333 REMARK 465 LEU B 334 REMARK 465 GLU B 335 REMARK 465 GLU B 336 REMARK 465 ARG B 337 REMARK 465 GLU B 338 REMARK 465 VAL B 339 REMARK 465 LEU B 340 REMARK 465 LYS B 341 REMARK 465 SER B 342 REMARK 465 LYS B 343 REMARK 465 GLU B 344 REMARK 465 LEU B 345 REMARK 465 GLY B 346 REMARK 465 VAL B 347 REMARK 465 ALA B 348 REMARK 465 THR B 349 REMARK 465 ASN B 350 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 36 CG CD OE1 OE2 REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 LEU A 192 CG CD1 CD2 REMARK 470 GLU A 238 CG CD OE1 OE2 REMARK 470 ARG A 278 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 288 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 ARG A 299 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 36 CG CD OE1 OE2 REMARK 470 GLU B 58 CG CD OE1 OE2 REMARK 470 GLU B 59 CG CD OE1 OE2 REMARK 470 TYR B 234 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 GLN B 239 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 63 0.19 -67.43 REMARK 500 TYR B 234 23.64 47.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7EHJ RELATED DB: PDB REMARK 900 RELATED ID: 7EHM RELATED DB: PDB DBREF 7EHN A 36 350 UNP P13995 MTDC_HUMAN 36 350 DBREF 7EHN B 36 350 UNP P13995 MTDC_HUMAN 36 350 SEQRES 1 A 315 GLU ALA VAL VAL ILE SER GLY ARG LYS LEU ALA GLN GLN SEQRES 2 A 315 ILE LYS GLN GLU VAL ARG GLN GLU VAL GLU GLU TRP VAL SEQRES 3 A 315 ALA SER GLY ASN LYS ARG PRO HIS LEU SER VAL ILE LEU SEQRES 4 A 315 VAL GLY GLU ASN PRO ALA SER HIS SER TYR VAL LEU ASN SEQRES 5 A 315 LYS THR ARG ALA ALA ALA VAL VAL GLY ILE ASN SER GLU SEQRES 6 A 315 THR ILE MET LYS PRO ALA SER ILE SER GLU GLU GLU LEU SEQRES 7 A 315 LEU ASN LEU ILE ASN LYS LEU ASN ASN ASP ASP ASN VAL SEQRES 8 A 315 ASP GLY LEU LEU VAL GLN LEU PRO LEU PRO GLU HIS ILE SEQRES 9 A 315 ASP GLU ARG ARG ILE CYS ASN ALA VAL SER PRO ASP LYS SEQRES 10 A 315 ASP VAL ASP GLY PHE HIS VAL ILE ASN VAL GLY ARG MET SEQRES 11 A 315 CYS LEU ASP GLN TYR SER MET LEU PRO ALA THR PRO TRP SEQRES 12 A 315 GLY VAL TRP GLU ILE ILE LYS ARG THR GLY ILE PRO THR SEQRES 13 A 315 LEU GLY LYS ASN VAL VAL VAL ALA GLY ARG SER LYS ASN SEQRES 14 A 315 VAL GLY MET PRO ILE ALA MET LEU LEU HIS THR ASP GLY SEQRES 15 A 315 ALA HIS GLU ARG PRO GLY GLY ASP ALA THR VAL THR ILE SEQRES 16 A 315 SER HIS ARG TYR THR PRO LYS GLU GLN LEU LYS LYS HIS SEQRES 17 A 315 THR ILE LEU ALA ASP ILE VAL ILE SER ALA ALA GLY ILE SEQRES 18 A 315 PRO ASN LEU ILE THR ALA ASP MET ILE LYS GLU GLY ALA SEQRES 19 A 315 ALA VAL ILE ASP VAL GLY ILE ASN ARG VAL HIS ASP PRO SEQRES 20 A 315 VAL THR ALA LYS PRO LYS LEU VAL GLY ASP VAL ASP PHE SEQRES 21 A 315 GLU GLY VAL ARG GLN LYS ALA GLY TYR ILE THR PRO VAL SEQRES 22 A 315 PRO GLY GLY VAL GLY PRO MET THR VAL ALA MET LEU MET SEQRES 23 A 315 LYS ASN THR ILE ILE ALA ALA LYS LYS VAL LEU ARG LEU SEQRES 24 A 315 GLU GLU ARG GLU VAL LEU LYS SER LYS GLU LEU GLY VAL SEQRES 25 A 315 ALA THR ASN SEQRES 1 B 315 GLU ALA VAL VAL ILE SER GLY ARG LYS LEU ALA GLN GLN SEQRES 2 B 315 ILE LYS GLN GLU VAL ARG GLN GLU VAL GLU GLU TRP VAL SEQRES 3 B 315 ALA SER GLY ASN LYS ARG PRO HIS LEU SER VAL ILE LEU SEQRES 4 B 315 VAL GLY GLU ASN PRO ALA SER HIS SER TYR VAL LEU ASN SEQRES 5 B 315 LYS THR ARG ALA ALA ALA VAL VAL GLY ILE ASN SER GLU SEQRES 6 B 315 THR ILE MET LYS PRO ALA SER ILE SER GLU GLU GLU LEU SEQRES 7 B 315 LEU ASN LEU ILE ASN LYS LEU ASN ASN ASP ASP ASN VAL SEQRES 8 B 315 ASP GLY LEU LEU VAL GLN LEU PRO LEU PRO GLU HIS ILE SEQRES 9 B 315 ASP GLU ARG ARG ILE CYS ASN ALA VAL SER PRO ASP LYS SEQRES 10 B 315 ASP VAL ASP GLY PHE HIS VAL ILE ASN VAL GLY ARG MET SEQRES 11 B 315 CYS LEU ASP GLN TYR SER MET LEU PRO ALA THR PRO TRP SEQRES 12 B 315 GLY VAL TRP GLU ILE ILE LYS ARG THR GLY ILE PRO THR SEQRES 13 B 315 LEU GLY LYS ASN VAL VAL VAL ALA GLY ARG SER LYS ASN SEQRES 14 B 315 VAL GLY MET PRO ILE ALA MET LEU LEU HIS THR ASP GLY SEQRES 15 B 315 ALA HIS GLU ARG PRO GLY GLY ASP ALA THR VAL THR ILE SEQRES 16 B 315 SER HIS ARG TYR THR PRO LYS GLU GLN LEU LYS LYS HIS SEQRES 17 B 315 THR ILE LEU ALA ASP ILE VAL ILE SER ALA ALA GLY ILE SEQRES 18 B 315 PRO ASN LEU ILE THR ALA ASP MET ILE LYS GLU GLY ALA SEQRES 19 B 315 ALA VAL ILE ASP VAL GLY ILE ASN ARG VAL HIS ASP PRO SEQRES 20 B 315 VAL THR ALA LYS PRO LYS LEU VAL GLY ASP VAL ASP PHE SEQRES 21 B 315 GLU GLY VAL ARG GLN LYS ALA GLY TYR ILE THR PRO VAL SEQRES 22 B 315 PRO GLY GLY VAL GLY PRO MET THR VAL ALA MET LEU MET SEQRES 23 B 315 LYS ASN THR ILE ILE ALA ALA LYS LYS VAL LEU ARG LEU SEQRES 24 B 315 GLU GLU ARG GLU VAL LEU LYS SER LYS GLU LEU GLY VAL SEQRES 25 B 315 ALA THR ASN HET J4F A 401 37 HET J49 A 402 30 HET J4F B 401 37 HET J49 B 402 30 HETNAM J4F 3-[4-[[1-[(4-CHLORANYL-1H-INDOL-2-YL)METHYL]-3,7- HETNAM 2 J4F DIMETHYL-2,6-BIS(OXIDANYLIDENE)PURIN-8-YL]AMINO]-6- HETNAM 3 J4F METHYL-PYRIMIDIN-2-YL]PROPANOIC ACID HETNAM J49 (2S)-2-[[4-[(4-AZANYL-6-OXIDANYL-PYRIMIDIN-5-YL) HETNAM 2 J49 CARBAMOYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID HETSYN J4F 3-(4-((1-((4-CHLORO-1H-INDOL-2-YL)METHYL)-3,7-DIMETHYL- HETSYN 2 J4F 2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)AMINO)-6- HETSYN 3 J4F METHYLPYRIMIDIN-2-YL)PROPANOIC ACID HETSYN J49 (4-(3-(4-AMINO-6-HYDROXYPYRIMIDIN-5-YL)UREIDO)BENZOYL)- HETSYN 2 J49 L-GLUTAMIC ACID FORMUL 3 J4F 2(C24 H23 CL N8 O4) FORMUL 4 J49 2(C17 H18 N6 O7) FORMUL 7 HOH *122(H2 O) HELIX 1 AA1 SER A 41 SER A 63 1 23 HELIX 2 AA2 ASN A 78 VAL A 95 1 18 HELIX 3 AA3 SER A 109 ASN A 122 1 14 HELIX 4 AA4 ASP A 140 VAL A 148 1 9 HELIX 5 AA5 SER A 149 ASP A 153 5 5 HELIX 6 AA6 HIS A 158 LEU A 167 1 10 HELIX 7 AA7 PRO A 174 GLY A 188 1 15 HELIX 8 AA8 SER A 202 THR A 215 1 14 HELIX 9 AA9 PRO A 236 ILE A 245 1 10 HELIX 10 AB1 THR A 261 ILE A 265 5 5 HELIX 11 AB2 ASP A 294 ARG A 299 1 6 HELIX 12 AB3 GLY A 311 LYS A 329 1 19 HELIX 13 AB4 SER B 41 SER B 63 1 23 HELIX 14 AB5 ASN B 78 VAL B 95 1 18 HELIX 15 AB6 SER B 109 ASP B 123 1 15 HELIX 16 AB7 ASP B 140 VAL B 148 1 9 HELIX 17 AB8 SER B 149 ASP B 153 5 5 HELIX 18 AB9 HIS B 158 LEU B 167 1 10 HELIX 19 AC1 PRO B 174 GLY B 188 1 15 HELIX 20 AC2 SER B 202 THR B 215 1 14 HELIX 21 AC3 PRO B 236 ILE B 245 1 10 HELIX 22 AC4 THR B 261 ILE B 265 5 5 HELIX 23 AC5 ASP B 294 ALA B 302 1 9 HELIX 24 AC6 GLY B 311 LYS B 330 1 20 SHEET 1 AA112 VAL A 38 VAL A 39 0 SHEET 2 AA112 TYR A 304 ILE A 305 1 O ILE A 305 N VAL A 38 SHEET 3 AA112 ALA A 270 ASP A 273 1 N VAL A 271 O TYR A 304 SHEET 4 AA112 ILE A 249 ALA A 253 1 N VAL A 250 O ALA A 270 SHEET 5 AA112 ASN A 195 GLY A 200 1 N VAL A 197 O ILE A 251 SHEET 6 AA112 THR A 227 SER A 231 1 O THR A 229 N VAL A 198 SHEET 7 AA112 THR B 227 SER B 231 -1 O ILE B 230 N VAL A 228 SHEET 8 AA112 ASN B 195 GLY B 200 1 N VAL B 196 O THR B 227 SHEET 9 AA112 ILE B 249 ALA B 253 1 O ALA B 253 N ALA B 199 SHEET 10 AA112 ALA B 270 ASP B 273 1 O ILE B 272 N VAL B 250 SHEET 11 AA112 TYR B 304 ILE B 305 1 O TYR B 304 N VAL B 271 SHEET 12 AA112 VAL B 38 VAL B 39 1 N VAL B 38 O ILE B 305 SHEET 1 AA2 3 ASN A 98 LYS A 104 0 SHEET 2 AA2 3 HIS A 69 VAL A 75 1 N LEU A 74 O ILE A 102 SHEET 3 AA2 3 GLY A 128 VAL A 131 1 O GLY A 128 N SER A 71 SHEET 1 AA3 3 ASN B 98 LYS B 104 0 SHEET 2 AA3 3 HIS B 69 VAL B 75 1 N VAL B 72 O ILE B 102 SHEET 3 AA3 3 GLY B 128 VAL B 131 1 O GLY B 128 N SER B 71 SHEET 1 AA4 2 ASN B 277 ARG B 278 0 SHEET 2 AA4 2 LEU B 289 VAL B 290 -1 O VAL B 290 N ASN B 277 CISPEP 1 LEU A 133 PRO A 134 0 3.06 CISPEP 2 VAL A 308 PRO A 309 0 -2.22 CISPEP 3 LEU B 133 PRO B 134 0 3.45 CISPEP 4 VAL B 308 PRO B 309 0 -2.93 CRYST1 113.169 113.169 113.670 90.00 90.00 120.00 P 65 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008836 0.005102 0.000000 0.00000 SCALE2 0.000000 0.010203 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008797 0.00000